Avidity is best known for developing antibody oligonucleotide conjugates (AOC) therapeutics, primarily for muscular dystrophy ...

(AskBio), a gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG, today announced that AB-1003 (also known as LION-101) has received rare pediatric disease ...

The global Duchenne muscular dystrophy (DMD) therapeutics market is set to grow by $4.4 billion from 2024 to 2028, with a ...

Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company, announced today that the United States (U.S.) Food and Drug Administration (FDA) granted Orphan Drug Designation and ...

Wave Life Sciences Pte. Ltd ( (WVE) ) has released its Q3 earnings. Here is a breakdown of the information Wave Life Sciences Pte. Ltd ...

and Robertson, D. Late onset, slowly progressive, sex-linked, pseudohypertrophic muscular dystrophy. Presented a thirty-fifth annual meeting of Society for Pediatric Research, Philadelphia ...

Research Triangle Park, North Carolina Saturday, November 9, 2024, 13:00 Hrs [IST] ...

Gain insight on Rigel Pharmaceuticals, AbbVie and more in the latest Market Talks covering the Health Care sector.

Tal Newberry passed from Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease on Christmas Day in ...

However, this is not the first time that the monkeys escaped the facility. In 2016, 19 monkeys escaped from Alpha Genesis and ...

SMN dysfunction is implicated in spinal muscular dystrophy and therapeutics exist to treat this ... the SMN complex could be ...

Discover six exosome therapy companies developing these tiny extracellular vesicles to treat an array of diseases.